Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Primary stenting better than angioplasty for AMI patients in early clinicals -- AHA conference.

This article was originally published in The Gray Sheet

Executive Summary

PRIMARY STENTING INSTEAD OF ANGIOPLASTY FOR ACUTE HEART ATTACK REDUCES RECURRENCE of myocardial infarction, according to the initial results of a study presented Nov. 11 at the American Heart Association scientific sessions in Orlando, Florida. Conducted by Harry Suryapranata et al., Weezenlanden Hospital, Zwolle, The Netherlands, the study found that MI recurred in 0.9% of patients receiving stents for treatment of acute myocardial infarction (AMI) compared to 7.8% of angioplasty AMI patients.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT009129

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel